CS248731B2 - Production method of the phenyl dihydropyridazinon derivatives - Google Patents

Production method of the phenyl dihydropyridazinon derivatives Download PDF

Info

Publication number
CS248731B2
CS248731B2 CS85202A CS20285A CS248731B2 CS 248731 B2 CS248731 B2 CS 248731B2 CS 85202 A CS85202 A CS 85202A CS 20285 A CS20285 A CS 20285A CS 248731 B2 CS248731 B2 CS 248731B2
Authority
CS
Czechoslovakia
Prior art keywords
methyl
compounds
formula
phenyl
dihydro
Prior art date
Application number
CS85202A
Other languages
Czech (cs)
English (en)
Inventor
Robert A Slater
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of CS248731B2 publication Critical patent/CS248731B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Hydrogenated Pyridines (AREA)
CS85202A 1984-01-13 1985-01-10 Production method of the phenyl dihydropyridazinon derivatives CS248731B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848400863A GB8400863D0 (en) 1984-01-13 1984-01-13 Chemical compounds

Publications (1)

Publication Number Publication Date
CS248731B2 true CS248731B2 (en) 1987-02-12

Family

ID=10554924

Family Applications (1)

Application Number Title Priority Date Filing Date
CS85202A CS248731B2 (en) 1984-01-13 1985-01-10 Production method of the phenyl dihydropyridazinon derivatives

Country Status (31)

Country Link
US (1) US4654342A (de)
EP (1) EP0150937B1 (de)
JP (3) JPS60158181A (de)
KR (1) KR920006781B1 (de)
CN (1) CN85101722A (de)
AT (1) ATE37179T1 (de)
AU (1) AU572252B2 (de)
CA (2) CA1251209A (de)
CS (1) CS248731B2 (de)
DD (1) DD231350A5 (de)
DE (1) DE3564941D1 (de)
DK (1) DK162519C (de)
ES (3) ES8607949A1 (de)
FI (1) FI850140L (de)
GB (1) GB8400863D0 (de)
GR (1) GR850068B (de)
HU (1) HU193591B (de)
IE (1) IE57969B1 (de)
IL (1) IL74031A (de)
JO (1) JO1351B1 (de)
MY (1) MY100124A (de)
NO (1) NO850129L (de)
NZ (1) NZ210816A (de)
PH (1) PH22136A (de)
PL (1) PL147123B1 (de)
PT (1) PT79819B (de)
RO (1) RO92607A (de)
SU (1) SU1396963A3 (de)
WO (1) WO1985003076A1 (de)
ZA (1) ZA85251B (de)
ZW (1) ZW385A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1251448A (en) * 1985-03-27 1989-03-21 William J. Coates Pyridazinone derivatives
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
ES2271247T3 (es) * 2001-02-27 2007-04-16 Migenix Corp. Aril-n-cianoguanidinas y metodo relacionados con ellas.
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (de) * 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Verwendung von PDE III Ihibitoren zur Reduktion der Herzgrösse in an Herzversagen leidenden Säugern
CA2628570A1 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
EP3210605A1 (de) * 2005-11-14 2017-08-30 Boehringer Ingelheim Vetmedica GmbH Verwendung von pde-iii-hemmern zur behandlung asymptomatischem (okkultem) herzversagen
EP1920785A1 (de) * 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Pimobendan-Cyclodextrin Komplex enthaltendes flüssiges Präparat
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
PT2370070E (pt) 2008-11-25 2013-11-18 Boehringer Ingelheim Vetmed Utilização de pimobendano para o tratamento da cardiomiopatia hipertrófica felina
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP6251038B2 (ja) 2011-03-01 2017-12-20 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcアゴニストの調製方法
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
CN113181110A (zh) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス,インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
WO2015082389A1 (en) 2013-12-04 2015-06-11 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN110117257B (zh) * 2018-02-05 2022-12-06 安徽省新星药物开发有限责任公司 一种含胍基的p2y12受体拮抗剂、制备方法及其用途
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822260A (en) * 1970-10-09 1974-07-02 American Cyanamid Co 6-(cyanophenyl)-4,5-dihydro-3(2h)-pyridazinones
BE791539A (fr) * 1971-11-19 1973-05-17 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
DE3063196D1 (en) * 1979-12-05 1983-06-16 Morishita Pharma Derivatives of 2-substituted-6-phenyl-3(2h)pyridazinone, their production and pharmaceutical compositions containing them
FI72718C (fi) * 1981-03-04 1987-07-10 Ciba Geigy Ag Foerfarande foer framstaellning av terapeutiskt verkande, substituerade 6-(4-morfolino-fenyl)-4,5-dihydro- 3(2h)-pyridazinoner och deras syraadditionssalter.
JPS58113180A (ja) * 1981-12-28 1983-07-05 Mitsui Toatsu Chem Inc ピリダジノン誘導体
DE3204375C2 (de) * 1982-02-09 1983-12-01 J. Rettenmaier & Söhne GmbH + Co, 7091 Holzmühle Verfahren zur Herabsetzung der Saugfähigkeit von Holz
JPS58140076A (ja) * 1982-02-09 1983-08-19 Mitsubishi Chem Ind Ltd ピリダジノン誘導体又はその塩類
DE3302021A1 (de) * 1983-01-22 1984-07-26 Basf Ag, 6700 Ludwigshafen 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones

Also Published As

Publication number Publication date
NO850129L (no) 1985-07-15
KR920006781B1 (ko) 1992-08-17
CN85101722A (zh) 1987-01-31
FI850140L (fi) 1985-07-14
DK162519C (da) 1992-03-30
IE850069L (en) 1985-07-13
GB8400863D0 (en) 1984-02-15
IE57969B1 (en) 1993-06-02
DD231350A5 (de) 1985-12-24
CA1260471A (en) 1989-09-26
EP0150937B1 (de) 1988-09-14
CA1260471C (de) 1989-09-26
AU572252B2 (en) 1988-05-05
MY100124A (en) 1989-12-18
CA1251209A (en) 1989-03-14
FI850140A0 (fi) 1985-01-11
ES549629A0 (es) 1987-03-01
JPS63313775A (ja) 1988-12-21
KR850005417A (ko) 1985-08-26
IL74031A0 (en) 1985-04-30
PT79819A (en) 1985-02-01
DK9185D0 (da) 1985-01-08
JO1351B1 (en) 1986-11-30
ES8607949A1 (es) 1986-06-01
AU3761185A (en) 1985-07-18
ES8706645A1 (es) 1987-07-01
NZ210816A (en) 1987-06-30
SU1396963A3 (ru) 1988-05-15
ZW385A1 (en) 1985-08-07
WO1985003076A1 (en) 1985-07-18
ZA85251B (en) 1986-08-27
ES8703846A1 (es) 1987-03-01
JPS63313776A (ja) 1988-12-21
ES554965A0 (es) 1987-07-01
RO92607A (ro) 1987-11-30
EP0150937A2 (de) 1985-08-07
ATE37179T1 (de) 1988-09-15
GR850068B (de) 1985-05-03
HUT37128A (en) 1985-11-28
JPS60158181A (ja) 1985-08-19
PH22136A (en) 1988-06-01
EP0150937A3 (en) 1985-08-21
PT79819B (en) 1987-01-07
HU193591B (en) 1987-11-30
ES539446A0 (es) 1986-06-01
PL251516A1 (en) 1985-12-17
DK162519B (da) 1991-11-11
PL147123B1 (en) 1989-04-29
DE3564941D1 (en) 1988-10-20
DK9185A (da) 1985-07-14
IL74031A (en) 1988-07-31
US4654342A (en) 1987-03-31

Similar Documents

Publication Publication Date Title
CS248731B2 (en) Production method of the phenyl dihydropyridazinon derivatives
RU2068844C1 (ru) Производные азотсодержащих гетероциклических соединений или их фармацевтически приемлемые соли с щелочными или щелочно-земельными металлами
DE69030206T2 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
CZ277698B6 (en) Racemic or optically active bis-aza-bicyclic compounds, process for preparing thereof, intermediates and use thereof
EP0208518B1 (de) 6-Phenyl-Pyridazin-Verbindungen
FR2479225A1 (fr) Imidazopyridines, leur preparation et leur utilisation comme agents cardiotoniques
EP0201988B1 (de) Dihydropyridazinonderivate
LU82728A1 (fr) 6-(pyridinyl)-3(2h)pyridazinones,leur preparation et leur utilisation therapeutique
EP0164247B1 (de) Dihydropyridine
US4766122A (en) Cyanoamidine compounds and derivatives thereof
US4766123A (en) Methylamidine compounds
US4962110A (en) Pyridazinone derivatives
LU83251A1 (fr) Derives d'imidazo(4,5-b)pyridine,leur preparation et leur utilisation comme agents cardiotoniques
JPS61212583A (ja) 2‐アミノピリミジノン誘導体
JPS61212582A (ja) ジヒドロピリダジノン誘導体
EP0197664A2 (de) 2-Aminopyrimidinonderivate
JPS61221177A (ja) シアノアルカンイミドアミド化合物
EP0146282A2 (de) Pyrazinon-Verbindungen
JPS6212764A (ja) ジヒドロピリダジノン誘導体
LU83320A1 (fr) 4,5-dihydro-6-(pyridinyl)-3(2h)-pyridazinones,leur preparation et leur utilisation comme agents cardiotoniques
JPH07316162A (ja) 三環式化合物
LU83322A1 (fr) 6-(pyridinyl)-3(2h)-pyridazinones 4-substitutees,leur preparation,leur utilisation comme agents cardiotoniques,et composes intermediaires.
CZ215992A3 (cs) Nové acylaminohetrazepinové deriváty, způsob výroby a farmaceutické prostředky sjejích obsahem